COVID variant BA.3.2: Symptoms, states, and what to know about the newly emerging 'Cicada' threat

"BA.3.2 has approximately 70-75 substitutions and deletions in the gene sequence of the spike protein relative to JN.1 and its descendant, LP.8.1."

"Because of BA.3.2's high number of mutations, the new variant has the potential to reduce protection from a previous infection or vaccination."

BA.3.2, or 'Cicada', is a new COVID-19 variant that has emerged from a long-circulating strain. It possesses approximately 70-75 mutations in the spike protein gene sequence compared to JN.1 and LP.8.1 variants. These mutations raise concerns about the variant's potential to diminish immunity from previous infections or vaccinations. Health organizations, including the CDC, are closely monitoring BA.3.2 due to its highly mutated nature and the implications for public health and vaccine efficacy.

Read at Fast Company